Z-0928-2013 Class II Terminated

Recalled by Sorin Group USA, Inc. — Arvada, CO

FDA device recall Z-0928-2013 was initiated by Sorin Group USA, Inc. on Jan 28, 2013 and is designated Class II. Reason for recall: Isoline defibrillation leads distributed may have internal insulation breach. The recall status is terminated (terminated Dec 9, 2015). Affected quantity: 1376 Isoline leads.

Recall details

Product Type
Devices
Report Date
Mar 20, 2013
Initiation Date
Jan 28, 2013
Termination Date
Dec 9, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1376 Isoline leads

Product description

Isoline Implantable Defibrillation Lead, Model Isoline 2CR5, 2CR6 and 2CT6. These lead models are indicated for ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life threatening arrhythmias

Reason for recall

Isoline defibrillation leads distributed may have internal insulation breach.

Distribution pattern

Worldlwide Distribution - USA (Nationwide) and worldwide to Argentina, Australia, Austria, Belgium, Brazil, Canada, Cuba, Czech Republic, Denmark, Egypt, France, Germany, Greece, Hong Kong, India, Iran, Ireland, Israel, Italy, Japan, Kuwait, Lebanon, Morocco, The Netherlands, Portugal, Russia, Saudi Arabia, Slovenia, Spain, Sweden, Switzerland, Tunisia, Ukraine, Uruguay and the United Kingdom.

Code information

Models: 2CR5, 2CR6 and 2CT6, Distributed From 03/19/08 To 01/21/13

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0928-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0928-2013. Report a data issue: hello@regdatalab.com.